JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Beneish M-Score: -2.45 (As of Jul. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603235 JiangXi Tianxin Pharmaceutical Co Ltd SHSE:603235
79 GF Score
Price ¥23.96
GF Value ¥28.99
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is JiangXi Tianxin Pharmaceutical Co Beneish M-Score?

JiangXi Tianxin Pharmaceutical Co SHSE:603235 -0.25% 79 Beneish M-Score is -2.45 as of Jul. 30, 2026. GuruFocus rates SHSE:603235 with a GF Score™ of 79/100 and a GF Value™ of ¥28.99 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,852 Consumer Packaged Goods companies, JiangXi Tianxin Pharmaceutical Co ranks worse than 56.43% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.45 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for JiangXi Tianxin Pharmaceutical Co's Beneish M-Score or its related term are showing as below:

SHSE:603235' s Beneish M-Score Range Over the Past 10 Years
Min: -2.88   Med: -2.58   Max: -1.5
Current: -2.45

During the past 8 years, the highest Beneish M-Score of JiangXi Tianxin Pharmaceutical Co was -1.50. The lowest was -2.88. And the median was -2.58.


JiangXi Tianxin Pharmaceutical Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for JiangXi Tianxin Pharmaceutical Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JiangXi Tianxin Pharmaceutical Co Beneish M-Score Chart

JiangXi Tianxin Pharmaceutical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 -2.46 -2.81 -2.13 -2.62

JiangXi Tianxin Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.37 -2.79 -2.87 -2.62 -2.45

SHSE:603235 vs KHC, GIS: Beneish M-Score Comparison

For the Packaged Foods subindustry, JiangXi Tianxin Pharmaceutical Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JiangXi Tianxin Pharmaceutical Co Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JiangXi Tianxin Pharmaceutical Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where JiangXi Tianxin Pharmaceutical Co's Beneish M-Score falls into.


SHSE:603235
79GF Score
JiangXi Tianxin Pharmaceutical Co Ltd SHSE:603235
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JiangXi Tianxin Pharmaceutical Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of JiangXi Tianxin Pharmaceutical Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.156+0.528 * 1.1203+0.404 * 0.9151+0.892 * 1.0141+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0695+4.679 * -0.010388-0.327 * 1.2948
=-2.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ¥484 Mil.
Revenue was 639.758 + 714.096 + 508.595 + 503.44 = ¥2,366 Mil.
Gross Profit was 255.85 + 252.731 + 202.663 + 228.429 = ¥940 Mil.
Total Current Assets was ¥2,793 Mil.
Total Assets was ¥6,254 Mil.
Property, Plant and Equipment(Net PPE) was ¥3,145 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥83 Mil.
Total Current Liabilities was ¥550 Mil.
Long-Term Debt & Capital Lease Obligation was ¥326 Mil.
Net Income was 147.004 + 131.275 + 104.29 + 137.446 = ¥520 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 136.886 + 138.812 + 148.552 + 160.737 = ¥585 Mil.
Total Receivables was ¥413 Mil.
Revenue was 618.911 + 594.99 + 546.967 + 572.115 = ¥2,333 Mil.
Gross Profit was 308.407 + 245.851 + 233.385 + 250.449 = ¥1,038 Mil.
Total Current Assets was ¥2,778 Mil.
Total Assets was ¥5,815 Mil.
Property, Plant and Equipment(Net PPE) was ¥2,715 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥76 Mil.
Total Current Liabilities was ¥426 Mil.
Long-Term Debt & Capital Lease Obligation was ¥202 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(484.496 / 2365.889) / (413.302 / 2332.983)
=0.204784 / 0.177156
=1.156

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1038.092 / 2332.983) / (939.673 / 2365.889)
=0.444963 / 0.397175
=1.1203

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2793.314 + 3144.565) / 6254.453) / (1 - (2777.864 + 2715.369) / 5814.847)
=0.050616 / 0.055309
=0.9151

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=2365.889 / 2332.983
=1.0141

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 2715.369)) / (0 / (0 + 3144.565))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(82.928 / 2365.889) / (76.464 / 2332.983)
=0.035052 / 0.032775
=1.0695

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((325.794 + 549.732) / 6254.453) / ((202.412 + 426.238) / 5814.847)
=0.139984 / 0.108111
=1.2948

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(520.015 - 0 - 584.987) / 6254.453
=-0.010388

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

JiangXi Tianxin Pharmaceutical Co has a M-score of -2.45 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.45 mean?
JiangXi Tianxin Pharmaceutical Co (SHSE:603235) has a Beneish M-Score of -2.45 as of Jul. 30, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on JiangXi Tianxin Pharmaceutical Co and its competitors. According to the industry distribution chart, JiangXi Tianxin Pharmaceutical Co ranks #1045 out of 1852 companies in the Consumer Packaged Goods industry, placing it in the top 56.4%.
Is JiangXi Tianxin Pharmaceutical Co's Beneish M-Score too high?
JiangXi Tianxin Pharmaceutical Co's current Beneish M-Score is -2.45. Based on the distribution chart, JiangXi Tianxin Pharmaceutical Co ranks #1045 out of 1852 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, JiangXi Tianxin Pharmaceutical Co has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JiangXi Tianxin Pharmaceutical Co's Beneish M-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, JiangXi Tianxin Pharmaceutical Co ranks #1045 out of 1852 companies for Beneish M-Score. This places JiangXi Tianxin Pharmaceutical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on JiangXi Tianxin Pharmaceutical Co and its competitors. JiangXi Tianxin Pharmaceutical Co's current Beneish M-Score is -2.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JiangXi Tianxin Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, JiangXi Tianxin Pharmaceutical Co (SHSE:603235) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.99, compared to a current price of ¥23.96 — trading 17.4% below its estimated fair value. The current Beneish M-Score is -2.45. JiangXi Tianxin Pharmaceutical Co's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For JiangXi Tianxin Pharmaceutical Co (SHSE:603235), the current Beneish M-Score is -2.45 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JiangXi Tianxin Pharmaceutical Co (SHSE:603235) Overvalued in 2026?

Based on GuruFocus' analysis, JiangXi Tianxin Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥23.96 is trading 17.4% below its estimated GF Value™ of ¥28.99. GuruFocus considers JiangXi Tianxin Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:603235:

  • Beneish M-Score: -2.45
  • GF Value™: ¥28.99 vs. price of ¥23.96 (17.4% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603235 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JiangXi Tianxin Pharmaceutical Co Business Description

Address Le'anjiang Industrial Park, Jiangxi Province, Leping, CHN, 333300
JiangXi Tianxin Pharmaceutical Co Ltd is engaged in the research and development, production and sales of monomeric vitamin products.
79GF Score

Get the complete analysis for SHSE:603235

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥23.96
Price
¥28.99
GF Value